Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study
- DOI
- 10.1182/bloodadvances.2025017519
- Published
- 2026-05-15
- Container
- Blood Advances
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2025017519,
title = {Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study},
author = {Jason Gotlib and Andreas Reiter and Deepti H. Radia and Iván Álvarez-Twose and Michael W. Deininger and Tracy I. George and Jens Panse and Andrzej Mital and Kristen M. Pettit and Alessandro M. Vannucchi and Uwe Platzbecker and Olivier Hermine and Amro Elshoury and Cristina Bulai Livideanu and Ruben Mesa and Celalettin Ustun and Massimo Triggiani and Ingunn Dybedal and Joseph G. Jurcic and Roberta Zanotti and Stephen T. Oh and Abdulraheem Yacoub and Elizabeth O. Hexner and Prithviraj Bose and Stephanie G. Lee and Wolfgang R. Sperr and Elizabeth A. Griffiths and Matthew Butler and Johannes Lübke and Ilda Bidollari and Hui-Min Lin and Svetlana Rylova and Saša Dimitrijević and Javier I. Muñoz-González and Daniel J. DeAngelo},
year = {2026},
journal = {Blood Advances},
doi = {10.1182/bloodadvances.2025017519},
url = {https://doi.org/10.1182/bloodadvances.2025017519}
}RIS
TY - JOUR TI - Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study AU - Jason Gotlib AU - Andreas Reiter AU - Deepti H. Radia AU - Iván Álvarez-Twose AU - Michael W. Deininger AU - Tracy I. George AU - Jens Panse AU - Andrzej Mital AU - Kristen M. Pettit AU - Alessandro M. Vannucchi AU - Uwe Platzbecker AU - Olivier Hermine AU - Amro Elshoury AU - Cristina Bulai Livideanu AU - Ruben Mesa AU - Celalettin Ustun AU - Massimo Triggiani AU - Ingunn Dybedal AU - Joseph G. Jurcic AU - Roberta Zanotti AU - Stephen T. Oh AU - Abdulraheem Yacoub AU - Elizabeth O. Hexner AU - Prithviraj Bose AU - Stephanie G. Lee AU - Wolfgang R. Sperr AU - Elizabeth A. Griffiths AU - Matthew Butler AU - Johannes Lübke AU - Ilda Bidollari AU - Hui-Min Lin AU - Svetlana Rylova AU - Saša Dimitrijević AU - Javier I. Muñoz-González AU - Daniel J. DeAngelo PY - 2026 JO - Blood Advances DO - 10.1182/bloodadvances.2025017519 UR - https://doi.org/10.1182/bloodadvances.2025017519 ER -
APA
Gotlib, J., Reiter, A., Radia, D. H., Álvarez-Twose, I., Deininger, M. W., George, T. I., Panse, J., Mital, A., Pettit, K. M., Vannucchi, A. M., Platzbecker, U., Hermine, O., Elshoury, A., Livideanu, C. B., Mesa, R., Ustun, C., Triggiani, M., Dybedal, I., Jurcic, J. G., Zanotti, R., Oh, S. T., Yacoub, A., Hexner, E. O., Bose, P., Lee, S. G., Sperr, W. R., Griffiths, E. A., Butler, M., Lübke, J., Bidollari, I., Lin, H., Rylova, S., Dimitrijević, S., Muñoz-González, J. I., & DeAngelo, D. J. (2026). Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study. Blood Advances. https://doi.org/10.1182/bloodadvances.2025017519
Source records
- crossref · retrieved 2026-09-26T14:35:25.474Z